Facts
The Canadian Centre for Ethics in Sport (CCES) alleges Rachelle Fleurant (the athlete) for a has violation of the Cananian Anti-Doping Pgogram (CADP) an anti-doping rule violation. The urine sample of the athlete, collected during in-competition doping control on October 20, 2012, revealed the presence of Clenbuterol and Oxandrolone, both prohibited anabolic agents, as well as hydrochlorothiazide, a prohibited diuretic.
History
Fleurant, in response to the CCES’s notification of the adverse analytical finding, acknowledged the anti-doping rule violation and a hearing was held to determine the sanction length.
Decision
Arbitrator McLaren imposed a sanction of two years ineligibility from sport, terminating October 20, 2014. The athlete is ineligible to participate in any capacity with any sport signatory to the Canadian Anti-Doping Program, including training with teammates.
